Combined cholinergic and 5-HT2 receptor activation suppresses thalamocortical oscillations in aged rats.
The present study investigated whether combined stimulation of the cholinergic system and 5-hydroxytryptamine (5-HT) subtype 2 receptors can suppress neocortical high-voltage spindles (HVSs) reflecting thalamocortical oscillations in aged rats. Cholinesterase inhibitors-tetrahydro-aminoacridine (THA: 1.0 and 3.0 mg/kg i.p.) and physostigmine (0.36 mg/kg i.p.)- and a 5-HT2 receptor agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI; 0.3 and 1.0 mg/kg SC)-suppressed HVSs in aged rats. A combination of subthreshold doses of THA (0.3 mg/kg i.p.) and DOI (0.1 mg/kg s.c.) suppressed HVSs more effectively than either drug alone. Furthermore, a 5-HT2 receptor antagonist, ketanserin (5.0 and 20.0 mg/kg s.c.), reduced the efficacy of THA (1.0 and 3.0 mg/kg i.p.) and physostigmine (0.12 and 0.36 mg/kg i.p.) in decreasing HVSs. THA and ketanserin slightly decreased, physostigmine tended to increase, and DOI significantly increased behavioral activity of the rats, demonstrating that the effects of the drugs on behavioral activity may be separated from their effects on generation of thalamocortical oscillations. The results suggest that activation of the cholinergic system and 5-HT2 receptors has additive effects in the suppression of thalamocortical oscillations in aged rats.
Jäkälä
P
P
Department of Neuroscience and Neurology, University of Kuopio, Finland. pekka.jakala@uku.li
Riekkinen
P
P
D000375:Aging / Q000502:physiology*; D000662:Amphetamines / Q000494:pharmacology; D000818:Animals; D002540:Cerebral Cortex / Q000502:physiology*; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D004357:Drug Synergism; D004569:Electroencephalography / Q000187:drug effects; D007650:Ketanserin / Q000494:pharmacology; D008297:Male; D010830:Physostigmine / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D011930:Reaction Time / Q000187:drug effects; D011950:Receptors, Cholinergic / Q000502:physiology*; D011985:Receptors, Serotonin / Q000502:physiology*; D013619:Tacrine / Q000494:pharmacology; D013788:Thalamus / Q000502:physiology*
D000662:Amphetamines; D002800:Cholinesterase Inhibitors; D011950:Receptors, Cholinergic; D011985:Receptors, Serotonin; D013619:Tacrine; D007650:Ketanserin; D010830:Physostigmine; C015952:4-iodo-2,5-dimethoxyphenylisopropylamine